No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1043-5. doi: 10.1158/1055-9965.EPI-06-0073.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / enzymology*
  • Arylamine N-Acetyltransferase / genetics
  • Case-Control Studies
  • Cytochrome P-450 CYP2E1 / genetics
  • Europe
  • Female
  • Genotype
  • Glutathione Transferase / genetics
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Stomach Neoplasms / enzymology*

Substances

  • Cytochrome P-450 CYP2E1
  • Arylamine N-Acetyltransferase
  • NAT2 protein, human
  • Glutathione Transferase
  • glutathione S-transferase M1